|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1998-8-31
|
|
pubmed:abstractText |
The aim of this multicenter randomized study was to compare conventional therapy with conventional plus high-dose therapy (HDT) and autologous bone marrow transplantation (ABMT) as front-line treatment for poor-prognosis non-Hodgkin's lymphoma (NHL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:CenturioniRR,
pubmed-author:ChisesiTT,
pubmed-author:CongiuA MAM,
pubmed-author:ContuAA,
pubmed-author:De SouzaCC,
pubmed-author:GuarnacciaCC,
pubmed-author:LeoneLL,
pubmed-author:MajolinoII,
pubmed-author:MangoniLL,
pubmed-author:NatiSS,
pubmed-author:OlivieriAA,
pubmed-author:PescostaNN,
pubmed-author:PorcelliniAA,
pubmed-author:RizzoliVV,
pubmed-author:RossiEE,
pubmed-author:RubagottiAA,
pubmed-author:SalvagnoLL,
pubmed-author:SantiniGG,
pubmed-author:SertoliM RMR,
pubmed-author:SoraccoMM,
pubmed-author:SprianoMM,
pubmed-author:TedeschiLL,
pubmed-author:VespignaniMM,
pubmed-author:VimercatiRR,
pubmed-author:ZambaldiGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
2796-802
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9704732-Adolescent,
pubmed-meshheading:9704732-Adult,
pubmed-meshheading:9704732-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9704732-Bleomycin,
pubmed-meshheading:9704732-Bone Marrow Transplantation,
pubmed-meshheading:9704732-Cisplatin,
pubmed-meshheading:9704732-Combined Modality Therapy,
pubmed-meshheading:9704732-Cyclophosphamide,
pubmed-meshheading:9704732-Cytarabine,
pubmed-meshheading:9704732-Dexamethasone,
pubmed-meshheading:9704732-Doxorubicin,
pubmed-meshheading:9704732-Etoposide,
pubmed-meshheading:9704732-Female,
pubmed-meshheading:9704732-Humans,
pubmed-meshheading:9704732-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:9704732-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9704732-Male,
pubmed-meshheading:9704732-Middle Aged,
pubmed-meshheading:9704732-Prednisone,
pubmed-meshheading:9704732-Prospective Studies,
pubmed-meshheading:9704732-Salvage Therapy,
pubmed-meshheading:9704732-Survival Rate,
pubmed-meshheading:9704732-Vincristine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
|
|
pubmed:affiliation |
Department of Haematology, San Martino Hospital, Genova, Italy. ginosantini@smartino.ge.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
